DS
TMDX icon

David Shaw’s Transmedics TMDX Stock Holding History

David Shaw’s Portfolio TMDX Stock Details TMDX Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		– Sell
-2,481
Closed -$210K – 5221
2026
Q1 		$247K Buy
+2,481
New +$324K ﹤0.01% 4135
2025
Q4 		– Sell
-37,270
Closed -$4.68M – 5010
2025
Q3 		$4.18M Sell
37,270
-39,774
-52% -$4.66M ﹤0.01% 2367
2025
Q2 		$10.3M Buy
77,044
+59,135
+330% +$6.49M 0.01% 1462
2025
Q1 		$1.2M Buy
17,909
+10,667
+147% +$734K ﹤0.01% 2976
2024
Q4 		$452K Buy
+7,242
New +$674K ﹤0.01% 3676
2024
Q3 		– Sell
-210,271
Closed -$32.4M – 4892
2024
Q2 		$31.7M Buy
+210,271
New +$25.2M 0.03% 645
2024
Q1 		– Sell
-12,564
Closed -$992K – 4742
2023
Q4 		$992K Buy
+12,564
New +$758K ﹤0.01% 3142
2023
Q3 		– Sell
-321,975
Closed -$27M – 4499
2023
Q2 		$27M Sell
321,975
-119,999
-27% -$9.19M 0.03% 716
2023
Q1 		$33.5M Buy
441,974
+67,308
+18% +$4.65M 0.04% 610
2022
Q4 		$23.1M Buy
374,666
+297,140
+383% +$15.8M 0.03% 834
2022
Q3 		$3.24M Buy
+77,526
New +$3.37M ﹤0.01% 2551

Other funds holding TMDX

BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return
Vanguard Portfolio Management
Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
NAMI
Nomura Asset Management International Philadelphia, Pennsylvania $66.6B AUM
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return
HRCM
Hood River Capital Management Palm Beach Gardens, Florida $13.8B AUM 163.97% 1-Year Est. Return
Dimensional Fund Advisors
Dimensional Fund Advisors Austin, Texas $552B AUM 44.19% 1-Year Est. Return
B
Braidwell Stamford, Connecticut $2.7B AUM 88.53% 1-Year Est. Return

David Shaw's TMDX Position: Q2 2026 in Review

David Shaw sold out of Transmedics (TMDX) in Q2 2026, closing a stake of 2,481 shares — an estimated $210K sold.

David Shaw first reported a position in TMDX in Q3 2022 and held it in 11 quarters. The position peaked at $33.5M in Q1 2023. 371 funds tracked by Wall St. Rank hold TMDX as of Q2 2026.

  • David Shaw reported no remaining Transmedics position as of Q2 2026 after selling out during the quarter.
  • David Shaw sold 2,481 Transmedics shares in Q2 2026, an estimated $210K.
  • David Shaw first reported a position in Transmedics in Q3 2022 and held it in 11 quarters.
  • David Shaw's Transmedics position peaked at $33.5M in Q1 2023.
  • 371 funds tracked by Wall St. Rank held Transmedics as of Q2 2026.

Based on D.E. Shaw & Co's 13F filing for Q2 2026, filed 14 Aug 2026.